As of 2025-05-17, the Intrinsic Value of Syncom Formulations (India) Ltd (524470.BO) is 3.39 INR. This 524470.BO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 17.60 INR, the upside of Syncom Formulations (India) Ltd is -80.80%.
The range of the Intrinsic Value is 2.70 - 4.52 INR
Based on its market price of 17.60 INR and our intrinsic valuation, Syncom Formulations (India) Ltd (524470.BO) is overvalued by 80.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 2.70 - 4.52 | 3.39 | -80.8% |
| DCF (Growth 10y) | 3.61 - 5.79 | 4.45 | -74.7% |
| DCF (EBITDA 5y) | 5.93 - 10.96 | 7.86 | -55.3% |
| DCF (EBITDA 10y) | 6.27 - 11.83 | 8.37 | -52.4% |
| Fair Value | 0.97 - 0.97 | 0.97 | -94.48% |
| P/E | 3.71 - 5.54 | 4.36 | -75.2% |
| EV/EBITDA | 3.92 - 7.86 | 5.86 | -66.7% |
| EPV | 2.03 - 2.65 | 2.34 | -86.7% |
| DDM - Stable | 1.01 - 2.09 | 1.55 | -91.2% |
| DDM - Multi | 2.20 - 3.61 | 2.74 | -84.4% |
| Market Cap (mil) | 16,544.00 |
| Beta | 1.72 |
| Outstanding shares (mil) | 940.00 |
| Enterprise Value (mil) | 17,118.05 |
| Market risk premium | 6.92% |
| Cost of Equity | 14.93% |
| Cost of Debt | 6.80% |
| WACC | 14.24% |